Final Abstract Submission Deadline: Oct 20, 2025 - Don’t miss out – Mid term Registration closes on Oct 15, 2025 - Submit your abstract and secure your spot today!
Final Abstract Submission Deadline: Oct 20, 2025 - Don’t miss out – Mid term Registration closes on Oct 15, 2025 - Submit your abstract and secure your spot today!
C2p Forum is excited to announce the European Congress on Rare Diseases and Orphan Drugs, set to take place on November 17-18, 2025, in Rome, Italy. This two-day event aims to bring together researchers, industry experts, stakeholders, and advocates from around the world to discuss the latest advancements, challenges, and opportunities in the field of rare diseases and orphan drugs. The conference’s main objective is to promote awareness, encourage collaboration, and accelerate efforts to address the unique challenges faced by individuals impacted by rare diseases.
Euro Rare Diseases 2025 will be an excellent venue for exchanging new findings and ideas among a wide range of experts involved in rare disease research, drug development, patient care, advocacy, and policy formulation. The event will feature keynote presentations, plenary sessions, panel discussions, workshops, and networking opportunities. Attendees will also have the chance to engage with exhibits showcasing the latest breakthroughs in rare disease research, diagnostics, and treatments.
Altogether Euro Rare Diseases is a key event focused on advancing research, encouraging innovation, and enhancing the well-being of people living with rare diseases.
Join us in Rome for the European Congress on Rare Diseases and Orphan Drugs, and be part of a transformative experience that will drive forward the frontiers of rare diseases and contribute to global health advancements. Register now to secure your place at this landmark event.
 
         
                
                 
             
                            Final Abstract Submission Deadline: Oct 20, 2025
 
                            Early Bird Registration: Sep 30, 2025
 
                            Mid Term Registration: Oct 15, 2025
 
                            Final/Onsite Registration: Nov 17, 2025
 
                            Founder of The Pituitary Gland Association Poland
Poland
 
                             
                            National and Kapodistrian University of Athens
Greece
 
                             
                            Cincinnati Children’s Hospital Medical Center
Ohio
 
                             
                            National and Kapodistrian University of Athens
Greece
 
                             
                            European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
Belgium
 
                             
                            National Hepatology and Tropical Medicine Research Institute (NHTMRI)
Egypt
 
                             
                            Jilin University
China
 
                             
                            Josep Carreras Leukaemia Research Institute CATALONIA
Spain
 
                                 
                            University of Basel
Switzerland
 
                                 
                            Hospital CUF Porto
Portugal
 
                                 
                            Alpha-1 Organization
Switzerland
 
                                 
                            Lumbini Medical College and Teaching Hospital
Nepal
 
                                 
                            University of Bern
Switzerland
 
                                 
                            ProductLife Group
France
 
                                 
                            University of Basel
Switzerland
 
                                 
                                The Rare Disease and Orphan Drugs Journal (RDODJ) is an international, peer-reviewed, open access journal for the publication of innovative research works on various aspects of this rapidly growing multidisciplinary and interdisciplinary field.
RDODJ will report on scientific advances in the genetics of rare diseases, the molecular basis of the pathologies, and translational research on diagnosis, prevention and treatment.
In addition, RDODJ aims to provide a forum for scientific studies and discussion covering the important regulatory, socio-economic and human science issues related to rare diseases and orphan drugs.
The ultimate objective of RDODJ is to promote the dissemination of research results and scientific discussion among the research community, practitioners, and patient-advocacy organizations.
Journal URL: https://www.oaepublish.com/rdodj
